Search Press releases Keywords From To 21 Jun 2004 UCB Pharma announces granting of European marketing authorisation for innovative transdermal therapy for symptomatic treatment of urge incontinence Read More 8 Jun 2004 Annual General Meeting of UCB Shareholders Read More 18 May 2004 Celltech and UCB Reach Worldwide Agreement on Development and Marketing of CDP870 Read More 18 May 2004 UCB S.A. launches a friendly offer to acquire Celltech Group plc, the leading UK-based biotech company Read More 27 Apr 2004 UCB 44212, the second analogue of UCB Pharma’s anti-epileptic, KEPPRA*, enters clinical study phase Read More 25 Mar 2004 UCB Group: confirmed increase of 2% in net results Read More Pagination First page Previous page Previous … Page 195 Page 196 Page 197 Page 198 Current page 199 Page 200 Page 201 Page 202 Page 203 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
